Singapore, May 22 -- Novo Nordisk Foundation has entered into strategic framework agreement with the World Health Organization (WHO) to advance global health. With the agreement, the Foundation expands its existing collaboration with WHO, committing to a granting frame of up toDKK 380 millionover the next four years.

The Foundation and WHO are deepening the partnership, adopting a more strategic approach through the signature of a framework agreement that will enable the two organisations to accelerate progress by working together.

This includes opportunities to collaborate on the promotion, provision and protection of health, addressing the growing burden of non-communicable diseases (NCDs) with emphasis on cardiometabolic diseases; cr...